Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
Falco P, Levis A, Stacchini A, Ciriello MM, Geuna M, Notari P, Omedè P, Pautasso M, Prato G, Strola G, Gioia D, Bonferroni M, Cametti G, Ferrero D, Freilone R, Gaidano G, Marinone C, Marmont F, Pollio B, Salvi F, Saglio G, Girotto M; Piedmont MDS Registry--Italy. Falco P, et al. Among authors: marinone c. Eur J Haematol. 2011 Nov;87(5):409-18. doi: 10.1111/j.1600-0609.2011.01676.x. Epub 2011 Aug 11. Eur J Haematol. 2011. PMID: 21711395
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G; Piedmont Study Group on Myleodysplastic Syndromes. Cilloni D, et al. Among authors: marinone c. J Clin Oncol. 2003 May 15;21(10):1988-95. doi: 10.1200/JCO.2003.10.503. J Clin Oncol. 2003. PMID: 12743153
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.
Ricca I, Rocci A, Drandi D, Francese R, Compagno M, Lobetti Bodoni C, De Marco F, Astolfi M, Monitillo L, Vallet S, Calvi R, Ficara F, Omedè P, Rosato R, Gallamini A, Marinone C, Bergui L, Boccadoro M, Tarella C, Ladetto M. Ricca I, et al. Among authors: marinone c. Leukemia. 2007 Apr;21(4):697-705. doi: 10.1038/sj.leu.2404544. Epub 2007 Feb 15. Leukemia. 2007. PMID: 17301820
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.
Ladetto M, Compagno M, Ricca I, Pagano M, Rocci A, Astolfi M, Drandi D, di Celle PF, Dell'Aquila M, Mantoan B, Vallet S, Pagliano G, De Marco F, Francese R, Santo L, Cuttica A, Marinone C, Boccadoro M, Tarella C. Ladetto M, et al. Among authors: marinone c. Blood. 2004 Jun 15;103(12):4644-9. doi: 10.1182/blood-2003-12-4412. Epub 2004 Feb 26. Blood. 2004. PMID: 14988160 Free article.
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Tarella C, Cuttica A, Caracciolo D, Zallio F, Ricca I, Bergui L, Gavarotti P, Marinone C, Pagano M, Rossi G, de Crescenzo A, Salomone A, Ladetto M, Boccadoro M, Pileri A. Tarella C, et al. Among authors: marinone c. Ann Hematol. 2001;80 Suppl 3:B123-6. doi: 10.1007/pl00022774. Ann Hematol. 2001. PMID: 11757693 Review. No abstract available.
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Cuttica A, Zallio F, Ladetto M, Di Nicola M, Caracciolo D, Magni M, Marinone C, Dell'Aquila M, Rosace M, Pileri A, Boccadoro M, Gianni AM, Tarella C. Cuttica A, et al. Among authors: marinone c. Cancer. 2003 Sep 1;98(5):983-92. doi: 10.1002/cncr.11610. Cancer. 2003. PMID: 12942566 Free article.
25 results